Biotechnology Research, Biotechnology research and development, Research and testing · 2 Employees
Phone Number: 33153100548
Email Address: hello.pep@pep-therapy.com
Overview
Employees
Access 11 Verified Employees Profiles for Pep TherapyUnlock Free Contacts Now
About
PEP-Therapy is a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology.
PEP-010, first drug candidate, is a pro-apoptotic agent which has demonstrated anti-tumor efficacy in a number of pre-clinical models and a good safety profile.
PEP-010 is currently evaluated in a Phase Ia/b clinical trial in patients with recurrent and/or metastatic solid tumors.
PEP-Therapy was founded in 2014 and builds on research results from Institut Curie and Sorbonne University. The company is backed by international investors.